Bryan Rous strain (Lot no. CT 929) was made available by Dr. Bryan of the National Cancer Institute. Various leucosis viruses, namely, RPL 12, erythroblastosis, myeloblastosis, and "RIF" were obtained through the Virus and Rickettsial Registry of the American Type Culture Collection.
Laboratory animals: Pregnant Syrian hamsters and weanling Hartley guinea pigs were obtained from the National Institutes of Health "General Purpose" colonies. Chickens and fertile eggs were obtained from Kimber Farms, Fremont, California, and the Truslow Farms, Inc., Chestertown, Maryland. Chicks and chick embryos used in these experiments were selected from hens shown to be free of naturally occurring avian leucosis virus using the Rubin test for "RIF" 3 and the more recently reported complement-fixation test for avian leucosis ("COFAL" test).4 Chick embryo fibroblast tissue cultures (CEF)5 used for propagating and assaying avian sarcoma and leucosis viruses, and methods used for preparing CF antigens from tissues and tissue cultures are described elsewhere.4 6 Stock virus and "viral" antigen preparations: Sarcomas were induced by the S-R and Bryan strains in 2-week-old Truslow or Kimber chickens by inoculating 0.1 ml of virus into the wing web and/or pectoral muscles. The sarcomas were removed after 7-10 days of progressive growth, and with a tissue grinder made into 20% suspensions in Eagle's basal medium (BME). Such suspensions clarified by centrifugation at 2,000 rpm/20 min in the International refrigerated centrifuge model PR-2 served as stock virus and as "viral" antigens in the CF test.
The S-R sarcoma viral pools used for inducing the hamster tumors reported on herein were made from wing web tumors produced in Truslow Farm chicks derived from a hen yielding offspring (embryos and chicks) which regularly showed high susceptibility to the S-R and Bryan strains of avian sarcoma. These virus-containing (viral) preparations revealed no evidence of contamination with avian leucosis virus when tested in CEF made from "RIF-free" embryos obtained from Kimber Farms.3 4 Tissue culture preparations of stock virus and CF antigens were prepared as follows: CEF cells free of RIF,3 grown in 60-mm Falcon Petri dishes3 4 in an atmosphere of 100% humidity and containing 5% CO2 were infected with 0.1 ml of the avian sarcoma and leucosis viruses. Baluda's medium7 containing 10% tryptose phosphate broth and 7% newborn calf serum was used. Virus and CF antigen preparations were generally made after 12-21 days incubation by suspending infected cells in tissue culture fluids, in most instances using 4 parts fluid to 1 part of packed cells; before testing they were frozen and thawed one or more times at -60'C. Stock tissue culture cell suspensions were usually clarified by centrifugation as described above for sarcoma extracts. All viral and antigen preparations were distributed in 1-dram screw-cap vials, and maintained at -60'C until used.
Assays for infectious virus: Infectious titers of cell-free avian sarcoma preparations were based on typical cell transformation effects in CEF tissue cultures, while the infectious titers of various leucosis viruses were determined with the use of Rubin's test for RIF3 and the newly described COFAL test;4 tests for infectious virus in primary and serially transplanted hamster tumors induced by S-R virus included these same procedures, using clarified 20% extracts in BME of hamster tumor prepared as described above for stock virus. Such clarified extracts were also tested for infectious virus by injecting 0.1 ml into wing web and pectoral muscles of "RIF-free" chicks at 7-15 days of age. We also used procedures similar to those described by Ahlstrom et al.1 and Svoboda et al.8 for inducing avian tumors with mammalian tumor cells by injecting whole-cell suepsnsions of hamster tumors into chicks 7-15 days of age. Hamster "tumor" antigen preparations: The methods employed for inducing subcutaneous and/or intraperitoneal tumors with the S-R viral strain in newborn hamsters and weanling guinea pigs, for transplanting such tumors to new hosts, and for collecting, processing, and pooling of antigens and antiserums, were identical to those used in our previous studies of adenovirusinduced hamster and rat tumor antigens.2
Complement-fixation procedures: The "micro" CF test9 used in previous studies of antigens in hamster tumors induced by adenovirus types 12 and 182 and by SV40 virus10 was employed for all antigen and antibody determinations.
Neutralization tests for measuring neutralizing antibodies for the S-R and Bryan Rous viruses were performed in CEF tissue cultures grown in test tubes as described in a previous report.12
Results.-Subcutaneous fibrosarcomas induced in newborn hamsters and wean-PROC. N. A. S. ling guinea pigs by subcutaneous injection of the S-R strain were in most important respects similar to those reported by AhIstrom and associates.' The newborn hamster appeared to be most susceptible, and the incidence of tumors and the incubation periods between injection and onset of tumors were influenced by the dosage of virus. It appeared that at least 105 ID50's of clarified but unfiltered virus as titrated in CEF tissue cultures4' 11 were required in order to induce tumors within 60 days in 80-100 per cent of hamsters injected as newborns. The tumors were generally induced more readily by virus obtained from sarcomatous chick tissues than by virus grown in CEF tissue cultures or on the CAM of chick embryos, no doubt due to the higher viral titers obtainable in the chick sarcomas. Injections of virus dilutions containing 103 ID50's or less required as long as 9 months before tumors appeared in hamsters, and the incidence of tumors was frequently quite low. Attempts to pass virus through 0.02 Selas filters eliminated all tumorigenic activity for hamsters from potent virus pools; Ahlstrom and Forsbyl reported similar difficulties in producing tumors with Seitz filtrates.
Complement-fixing antibodies in hamsters and guinea pigs with S-R-induced tumors: Table 1 shows representative cross reactions in the CF test of hamster "tumor" and chicken sarcoma "viral" antigens (S-R strain) with serums from hamsters and guinea pigs carrying large tumors induced by S-R virus. Although not shown in the table, we found that these serums gave comparable serum and antigen titers when they were tested with viral antigens prepared from chicken sarcomas induced by the Bryan strain of avian sarcoma. The S-R hamster tumor system resembled the adenovirus type 12 hamster tumor system2 in that antigens prepared from hamster tumors larger than 2.0 cm in diameter frequently showed a great deal of necrosis, hemorrhage, and anticomplementary (AC) activity, whereas smaller tumors (1.5 cm or less), while equally antigenic, showed little or no necrosis and usually no AC activity. As in the adenovirus hamster tumor system, AC activity in the antigen preparations was generally associated with the higher levels of CF antibodies (1:40 or greater) characteristically found in the serums of the hamsters with large (2.0 cm or greater) tumors.
Progressive development of complement-fixing (CF) antibodies in hamster serums: Serum specimens taken from hamsters at various intervals after subcutaneous injection of S-R virus revealed gradual development of complement-fixing antibodies when tested with hamster "tumor" and chicken sarcoma "viral" antigens (4-8 units) . In a representative experiment shown in Table 2 , serum antibodies in- creased in titer in relationship to the size of the tumors and/or time of exposure to tumor. This pattern of reactivity was quite similar to that observed previously with the adenovirus 12 and 18 and SV40 hamster tumor systems.2' 10 Serum antibodies did not appear in those hamsters failing to develop S-R-induced tumors.
Tumors were also induced by S-R virus in weanling guinea pigs, although the tumors appeared later (generally 60-90 days after injection) than in newborn hamsters. The appearance of the tumors was followed by gradual development of serum antibodies to viral as well as hamster tumor antigens. However, we noted a tendency for tumors to regress in some of the guinea pigs following which the serum antibodies gradually decreased in titer; guinea pigs which failed to develop tumors did not develop detectable CF antibodies at any time.
Serial transplantation: Serial subcutaneous transplantation of hamster tumor tissue in newborn and weanling hamsters yielded rapidly growing tumors that often killed the hamsters within 15-20 days. Although antigens were demonstrable in the tumors, the early demise of the hamsters rendered antibody studies impossible. Fortunately, however, several transplant lines were finally established which did not destroy the hamsters until after 30-60 days. As was observed in virus-induced primary tumors, the effects of tumor size and time of exposure on the development of serum antibodies were again apparent, larger tumors and longer periods of exposure to large tumors resulting in higher antibody titers; hamsters which failed to develop progressively growing tumors after transplantation again failed to develop antibodies. One attempt to transplant a guinea pig tumor to weanling hamsters was unsuccessful.
Antigens in hamster tumor cells grown in tissue cultures: S-R hamster tumor cells grew readily when trypsinized and cultured in Falcon plastic Petri dishes, in screw-capped test tubes and 1-liter (C 32) flasks.11 When tissue culture-grown tumor cells were suspended in BME at a 1-4 (20%) ratio and were frozen and thawed 3 times, CF antigens were demonstrated which equalled in titer those exhibited by tumor suspensions. Antigens persisted through 10 subcultures in tissue cultures, and when the cells were transplanted subcutaneously into newborn or weanling hamsters, they grew readily into solid tumors. In general, the amount of CF antigen demonstrated in hamster tumors produced by transplants of tissue culture-grown hamster tumor cells was higher than that ordinarily observed in hamster tumors maintained by hamster-to-hamster transplantation.
In certain instances, after many serial hamster tumor transplantations (20 or more), the tumors grew more slowly, requiring several months to reach large size (3.0 cm or greater); in these instances even large tumors showed surprisingly little necrosis. Although CF antibodies eventually appeared in such hamsters, the antigen content of the tumors was sometimes quite low in titer (1:2 or less). Tissue cultures prepared by trypsinizing such slow-growing tumors1' occasionally yielded cell lines that also grew slowly and which contained little or no measurable antigen, failed to survive freezing at low temperatures, and failed to grow when transplanted into newborn hamsters. However, in other instances, cell lines were obtained that grew rapidly, contained CF antigen, and transplanted readily back into the hamster. In the latter instances, the subsequent tumors yielded high antigen titers (1: 32 or >) and resulted in high-level antibody responses as early as [20] [21] [22] [23] [24] [25] per cent extracts of the same hamster tumors clarified as described above in Methods. It was interesting, on the other hand, to find that cell-free extracts of chick sarcomas induced by hamster tumor explants contained infectious virus which was easily demonstrated in CEF tissue cultures as well as by injection of chicks. Thus, despite the virtual absence of demonstrable infectious virus, hamster tumor cells injected as viable explants into susceptible chicks were found to possess a factor which induced sarcomas containing avian sarcoma virus. In this latter respect, the hamster cells may resemble the nonproducer (NP) cells of chicken sarcoma described by Hanafusa et al.14 Since there was no evidence of a Rous-associated virus (RAV) either in the hamster tumors or in the chicks, the mechanism of reactivation of S-R virus appears to be different from that described for the Bryan strain.14 The relative absence of infectious virus in hamster tumors is also indicated by the fact that serums of hamsters with very high CF antibodies to the tumor and viral antigens of the S-R and Bryan strains failed to reveal evidence of neutralizing antibodies to either strain of avian sarcoma virus,13 thus confirming that demonstrably infectious S-R virus is not replicated to any large extent in virus-injected hamsters, regardless of whether or not they develop tumors.
Group reactivity and specificity of S-R hamster serum reactions: Pooled serums of hamsters with S-R tumors reacted with antigens prepared from various avian sarcoma and leucosis viruses grown in CEF tissue cultures. In Table 3 , it can be seen that CF antigens were demonstrated not only in S-R virus-induced hamster and chicken tumors and in tissue culture suspensions of hamster tumors, but also in preparations made from Bryan strain of Rous sarcoma, and from such standard strains of leucosis virus as RPL 12, erythroblastosis, and RIF. Comparable antigen-antibody reactions were observed in all the avian sarcoma and leucosis viral systems studied, whereas antigens prepared in the same way from normal tissues and tissue cultures of normal cells failed to show any evidence of antigen activity. The tumor dependence and specificity of the hamster antibody reactions were also attested to by the failure of the various antigens to react with pooled serums taken from hamsters prior to onset of tumor. Group reactivity was evident in the guinea pig as well as in the hamster serum antibody responses.
The broad cross-reactivities of hamster and guinea pig antibodies were regarded as particularly interesting, since neutralization test studies have shown the S-R strain to be immunologically distinct from the Bryan strain of RSV and from strains of various leucosis viruses.12 The antigen reactions occurred only with serums of hamsters bearing S-R virus-induced tumors and not with serums of hamsters carrying tumors induced by other oncogenic viruses, and appeared to be group-specific in that S-R hamster serums containing 4-8 units of specific antibody did not react with normal chicken or hamster tissue antigens or with the tumor antigens found in SV40 and adenovirus-induced hamster tumors (Table 3) . 2 10 Some properties of the CF antigens found in hamster tumors, avian sarcomas, and leucosis viral preparations: The CF antigens in the hamster tumors were almost completely "soluble"; they could not be sedimented when centrifuged at 30,000 rpm for 90 min using the no. 30 head of the Model L Spinco centrifuge.'2 In this respect, the S-R hamster tumor antigens resembled the noninfectious soluble antigens in hamster tumors induced by adenovirus types 12 and 182 and SV40 virus.'0 Studies of the properties of the antigens of other avian virus CF antigens (Table 3) revealed that they also were in large part "soluble"; centrifugation at 30,000 rpm (59,364 g's) for 70 min failed to sediment more than 10 per cent of the total amount of CF antigen in tissue culture-grown preparations of RPL 12,erythroblastosis, and RIF strains.6 Similar results were obtained with antigens made from the Bryan and S-R strains of chicken sarcoma tissues.6' 12 The effect of heating to 560C virtually eliminated the virus-free hamster tumor antigen, reducing antigen titers 16-fold or more.'2 Viral antigens prepared from an S-R strain wing web sarcoma and from the RPL 12 strain of avian leucosis grown in CEF were reduced 4-8-fold in titer by heating. Treatment More recently, my associates and I reported specific complement-fixing antigens in hamster and rat tumor cells induced by adenovirus types 12 and 182 and in hamster tumors induced by SV40 virus.'0 These antigens were "soluble" and could not be explained by replicating infectious virus particles, yet they possessed a degree of viral specificity explainable only by the continuous presence in the tumor cells of genetic information from the respective viral genomes. This conclusion seemed particularly inescapable in the case of adenovirus type 12-induced tumor cells in which one subunit of the virus, namely, the type-specific "C" antigen was found to be present, whereas another subunit, the group-reactive "A" antigen, was absent. 22 In this report, we have presented observations on "soluble" CF antigens which persisted not only in hamster and guinea pig tumors carried through more than 20 serial passages of tumor cell transplants in hamsters, but also numerous undetermined generations of hamster tumor cells grown in tissue cultures. The CF antibodies produced in the serums of tumored hamsters were reactive with antigens in viral preparations of the Bryan as well as the S-R strains of avian sarcoma, and also with CF antigens found in various leucosis virus preparations.
Since leucosis viruses possess certain properties similar to those of myxoviruses,6 23, 24 it may be suggested that the soluble antigens found in the absence of infectious virus in the hamster tumors and avian leucosis viruses may, like the "S" antigens of influenza viruses, represent a structural subunit of the virus; this, however, remains to be demonstrated. The S-R soluble antigen, like the soluble (S) antigens of certain myxoviruses, is ether-resistant and appears to be a common antigen shared by the various leucosis viruses.6 It is also "group-specific," since no reactions could be demonstrated with normal chicken or chick embryo tissue or with antigens of the various representative myxoviruses grown in chick embryo cells.6
From a practical point of view, perhaps the most valuable aspect of the S-R strain hamster tumor system is that it has furnished a group-specific mammalian antiserum which is useful for detecting not only the CF antigens of avian sarcoma viruses,6 but also inapparent infections of chick embryo tissue cultures with various leucosis virus strains, such as RPL 12, erythroblastosis, myeloblastosis, RIF, and RAV.4 Furthermore, the complement-fixation test for avian leucosis (COFAL test),4 which is based on the use of group-specific leucosis antibodies in hamster serums, appears to be more specific and at least as sensitive as Rubin's test for RIF,3 and thus provides a comparatively simple and relatively rapid procedure for testing chicken populations for active infections with naturally occurring leucosis virus.25 * Present address:-The Children's Hospital of Philadelphia. PROCEEDINGS, 51, 432 (1964) .
23Epstein, M. A., Brit. J. Cancer, 10, 33 (1958) . 24 Crawford, L. V., and E. M. Crawford, Virology, 13, 227 (1961 Communicated by Andr6 Cournand, March 24, 1964 In the physical field, by far the most advanced in our scientific knowledge, the concept of distribution of the various physical quantities involved has become of paramount importance for a thorough rational explanation of the intimate mechanisms of the phenomena. In the physiological field the knowledge of the distribution of different physical quantities must be of as much importance. It is fitting that one should start by studying the laws of distribution of the simplest of these quantities, namely, those of the gas flow throughout the lung and of the blood flow through the organs.
The mathematical bases for assessing the law of distribution of specific tidal volume throughout the lung have been previously established.1' 2 The concept thus derived, which involves appropriate integral transforms of the Laplace type, has already been applied to the study of the distribution of specific ventilation in the normal as well as in the diseased lungs.3 We shall deal hereafter with the distribution of specific blood flow through organs and tissues where the nucleus of the transformation in the integral equations inferred totally differs from the Laplace kernel
